AMA on health claims
This article was originally published in The Tan Sheet
Executive Summary
American Medical Association "strongly opposes" FDA's decision to "allow a lower standard - the so-called weight of the scientific evidence standard - to be used in deciding whether a health claim can be placed on the labeling of a conventional food product," according to Feb. 21 comments. The "weight of the scientific evidence standard" would allow the use of health claims "that have a reasonable chance of being erroneous" and "actually could confuse consumers" rather than help them to make informed decisions, the medical group contends. Comments respond to FDA's decision to no longer hold health claims for food, supplements to significant scientific agreement standard (1"The Tan Sheet" Dec. 23, 2002, p. 10). AMA also says it is working with Congress to modify DSHEA...
You may also be interested in...
Qualified Health Claims “Reasonable Consumer” Standard Adopted By FDA
FDA will employ a "reasonable consumer" standard, rather than an "ignorant, unthinking and credulous" consumer standard, to determine whether dietary supplement and food labeling is misleading, the agency announced Dec. 18
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.